We’re thrilled to announce $14.5 million in new funding through the 2025 Terry Fox New Frontiers Program Project Grants (PPGs), supporting cutting-edge research in sarcomas, bladder cancer, high-risk brain cancer and immunotherapies.
These multi-institutional teams are pushing the boundaries of cancer research:
Dr. Michele Ardolino’s (Ottawa Hospital Research Institute) team will explore why some patients don’t respond to immunotherapy and how the entire body can be empowered to eliminate cancer through more personalized, targeted therapies.
Dr. Peter Black (Vancouver Prostate Centre, University of British Columbia) and his team aim to personalize treatment for patients with bladder cancer by developing tools to measure how a patient is responding to therapy in real time. This work could significantly improve the standard of care and reduce the number of patients who undergo precautionary bladder removal.
- To predict/determine response to neoadjuvant therapy (Alex Wyatt, Gillian Vandekerkhove, Marie-Pier St-Laurent, Ali Bashashati, Bernie Eigl, Gang Wang)
- Investigate the tumor immune microenviroment in the context of neoadjuvant therapy (Morgan Roberts, Faraz Hach, Govind Kaigala, Ewan Gibb)
- Develop novel therapies against oncofetal chondroitin sulfate (Mads Daugaard)
Dr. uri tabori (The Hospital for Sick Children) will lead a team pioneering a new treatment approach called “cancer interception” to detect and eliminate high-risk brain tumours (gliomas) in children before they become life-threatening.
With renewed Terry Fox funding, a research team co-led by Drs. David Huntsman (UBC, BC Cancer) and Torsten Nielsen (UBC, Vancouver General Hospital) aim to improve early detection and develop more precise, less toxic treatments for six types of sarcoma affecting children, adolescents and young adults.
Together, these projects bring the total to 23 active PPGs, each advancing Terry’s vision of bold, collaborative science to transform cancer care.
This work is made possible thanks to the incredible generosity of donors to the Terry Fox Foundation.
Source: Terry Fox Research Institute (TFRI). Read more about this life-changing cancer research: https://lnkd.in/gxsdQbaA
